Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

A phase I study of targeted, dose-escalated intravenous busulfan in combination with etoposide as myeloablative therapy for autologous stem cell transplantation in acute myeloid leukemia.

Mannis GN, Andreadis C, Logan AC, Damon LE, Benet LZ, Ai WZ, Gaensler KM, Kaplan LD, Koplowicz YB, Linker CA, Olin RL, Sayre PH, Smith CC, Sudhindra A, Venstrom JM, Wolf JL, Martin TG 3rd.

Clin Lymphoma Myeloma Leuk. 2015 Jun;15(6):377-83. doi: 10.1016/j.clml.2015.02.016. Epub 2015 Feb 14.

PMID:
25776193
2.

Autologous transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia achieves outcomes similar to allogeneic transplantation: results of CALGB Study 10001 (Alliance).

Wetzler M, Watson D, Stock W, Koval G, Mulkey FA, Hoke EE, McCarty JM, Blum WG, Powell BL, Marcucci G, Bloomfield CD, Linker CA, Larson RA.

Haematologica. 2014 Jan;99(1):111-5. doi: 10.3324/haematol.2013.085811. Epub 2013 Sep 27.

3.

Detection of minimal residual disease following induction immunochemotherapy predicts progression free survival in mantle cell lymphoma: final results of CALGB 59909.

Liu H, Johnson JL, Koval G, Malnassy G, Sher D, Damon LE, Hsi ED, Bucci DM, Linker CA, Cheson BD, Stock W.

Haematologica. 2012 Apr;97(4):579-85. doi: 10.3324/haematol.2011.050203. Epub 2011 Nov 18.

4.

Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909.

Damon LE, Johnson JL, Niedzwiecki D, Cheson BD, Hurd DD, Bartlett NL, Lacasce AS, Blum KA, Byrd JC, Kelly M, Stock W, Linker CA, Canellos GP.

J Clin Oncol. 2009 Dec 20;27(36):6101-8. doi: 10.1200/JCO.2009.22.2554. Epub 2009 Nov 16.

5.

Granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting cellular immunotherapy in combination with autologous stem cell transplantation (ASCT) as postremission therapy for acute myeloid leukemia (AML).

Borrello IM, Levitsky HI, Stock W, Sher D, Qin L, DeAngelo DJ, Alyea EP, Stone RM, Damon LE, Linker CA, Maslyar DJ, Hege KM.

Blood. 2009 Aug 27;114(9):1736-45. doi: 10.1182/blood-2009-02-205278. Epub 2009 Jun 25.

6.

Auto-SCT for AML in second remission: CALGB study 9620.

Linker CA, Owzar K, Powell B, Hurd D, Damon LE, Archer LE, Larson RA; Cancer and Leukemia Group B.

Bone Marrow Transplant. 2009 Sep;44(6):353-9. doi: 10.1038/bmt.2009.36. Epub 2009 Mar 16.

PMID:
19289999
7.

A phase II study of continuous infusion homoharringtonine and cytarabine in newly diagnosed patients with chronic myeloid leukemia: CALGB study 19804.

Stone RM, Donohue KA, Stock W, Hars V, Linker CA, Shea T, Deangelo DJ, Marcucci G, Bloomfield CD, Larson RA; Cancer and Leukemia Group B.

Cancer Chemother Pharmacol. 2009 Apr;63(5):859-64. doi: 10.1007/s00280-008-0805-8. Epub 2008 Aug 1.

PMID:
18670778
8.

Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG).

Fitzgerald PA, Goldsby RE, Huberty JP, Price DC, Hawkins RA, Veatch JJ, Dela Cruz F, Jahan TM, Linker CA, Damon L, Matthay KK.

Ann N Y Acad Sci. 2006 Aug;1073:465-90.

PMID:
17102115
9.

Adoptive immunotherapy by allogeneic stem cell transplantation for metastatic renal cell carcinoma: a CALGB intergroup phase II study.

Rini BI, Halabi S, Barrier R, Margolin KA, Avigan D, Logan T, Stadler WM, McCarthy PL, Linker CA, Small EJ; Cancer and Leukemia Group B; Eastern Cooperative Oncology Group; Southwestern Oncology Group.

Biol Blood Marrow Transplant. 2006 Jul;12(7):778-85.

10.
11.

Treatment of acute leukemia with idarubicin, etoposide and cytarabine (IDEA). A randomized study of etoposide schedule.

Damon LE, Johnston LJ, Ries CA, Rugo HS, Case D, Ault K, Linker CA.

Cancer Chemother Pharmacol. 2004 Jun;53(6):468-74. Epub 2004 Jan 29.

PMID:
15138711
12.

Autologous stem cell transplantation for acute myeloid leukemia.

Linker CA.

Bone Marrow Transplant. 2003 May;31(9):731-8. Review.

PMID:
12732879
13.

Autologous stem cell transplantation for advanced acute myeloid leukemia.

Linker CA, Damon LE, Ries CA, Navarro WA, Case D, Wolf JL.

Bone Marrow Transplant. 2002 Feb;29(4):297-301.

14.

The effect of graft purging with 4-hydroperoxycyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemia.

Miller CB, Rowlings PA, Zhang MJ, Jones RJ, Piantadosi S, Keating A, Armitage JO, Calderwood S, Harris RE, Klein JP, Lazarus HM, Linker CA, Sobocinski KA, Weisdorf D, Horowitz MM.

Exp Hematol. 2001 Nov;29(11):1336-46.

PMID:
11698130
15.

Autologous stem cell transplantation for acute lymphocytic leukemia in adults.

Martin TG, Linker CA.

Hematol Oncol Clin North Am. 2001 Feb;15(1):121-43. Review.

PMID:
11253604
16.

High-dose chemotherapy and hematopoietic stem cell rescue for breast cancer: experience in California.

Damon LE, Hu WW, Stockerl-Goldstein KE, Blume KG, Wolf JL, Gold E, Cecchi GR, Irwin D, Glaspy J, Territo I, Miller W, Mason JR, Linker CA.

Biol Blood Marrow Transplant. 2000;6(5):496-505.

17.

High-dose chemotherapy (CTM) for breast cancer.

Damon LE, Wolf JL, Rugo HS, Gold E, Zander AR, Cassidy M, Cecchi G, Cohen N, Irwin D, Tracy M, Ries CA, Linker CA.

Bone Marrow Transplant. 2000 Aug;26(3):257-68.

18.

Autologous stem cell transplantation for acute myeloid leukemia in first remission.

Linker CA, Ries CA, Damon LE, Sayre P, Navarro W, Rugo HS, Rubin A, Case D, Crilley P, Topolsky D, Brodsky I, Zamkoff K, Wolfe JL.

Biol Blood Marrow Transplant. 2000;6(1):50-7.

19.

Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in chronic myelogenous leukemia in chronic phase.

Gale RP, Park RE, Dubois RW, Herzig GP, Hocking WG, Horowitz MM, Keating A, Kempin S, Linker CA, Schiffer CA, Wiernik PH, Weisdorf DJ, Rai KR.

Leuk Res. 1999 Sep;23(9):817-26.

PMID:
10475621
20.

Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute myelogenous leukemia in 1st remission.

Gale RP, Park RE, Dubois RW, Herzig GP, Hocking WG, Horowitz MM, Keating A, Kempin S, Linker CA, Schiffer CA, Wiernik PH, Weisdorf DJ, Rai KR.

Leuk Res. 1999 Aug;23(8):709-18.

PMID:
10456668
22.

Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute lymphoblastic leukemia in first remission.

Gale RP, Park RE, Dubois RW, Herzig GP, Hocking WG, Horowitz MM, Keating A, Kempin S, Linker CA, Schiffer CA, Wiernik PH, Weisdorf DJ, Rai KR.

Leuk Res. 1998 Nov;22(11):973-81.

PMID:
9783798
23.

A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111.

Larson RA, Dodge RK, Linker CA, Stone RM, Powell BL, Lee EJ, Schulman P, Davey FR, Frankel SR, Bloomfield CD, George SL, Schiffer CA.

Blood. 1998 Sep 1;92(5):1556-64.

24.

Risk-adapted treatment of adult acute lymphoblastic leukemia (ALL).

Linker CA.

Leukemia. 1997 May;11 Suppl 4:S24-7. Review.

PMID:
9179278
25.

High-dose cytarabine dose modification reduces the incidence of neurotoxicity in patients with renal insufficiency.

Smith GA, Damon LE, Rugo HS, Ries CA, Linker CA.

J Clin Oncol. 1997 Feb;15(2):833-9.

PMID:
9053511
26.

The role of endoscopic evaluation in patients with suspected intestinal graft-versus-host disease after allogeneic bone-marrow transplantation.

Terdiman JP, Linker CA, Ries CA, Damon LE, Rugo HS, Ostroff JW.

Endoscopy. 1996 Oct;28(8):680-5.

PMID:
8934085
27.

Polymyositis as a manifestation of chronic graft-versus-host disease.

Parker P, Chao NJ, Ben-Ezra J, Slatkin N, Openshaw H, Niland JC, Linker CA, Greffe BS, Kashyap A, Molina A, Nademanee A, O'Donnell MR, Planas I, Sheibani K, Smith EP, Snyder DS, Spielberger R, Stein AS, Stepan DE, Blume KG, Forman SJ.

Medicine (Baltimore). 1996 Sep;75(5):279-85. Review.

29.
30.

Immune globulin therapy in allogeneic bone marrow transplant: a critical review.

Guglielmo BJ, Wong-Beringer A, Linker CA.

Bone Marrow Transplant. 1994 May;13(5):499-510. Review.

PMID:
8054903
31.

Post-remission cytopenias following intense induction chemotherapy for acute myeloid leukemia.

Damon LE, Rugo HS, Ries CA, Linker CA.

Leukemia. 1994 Apr;8(4):535-41.

PMID:
8152248
32.

High-dose chemotherapy for peripheral stem cell procurement in leukemia, lymphoma and multiple myeloma.

Rugo HS, Damon LE, Ries CA, Wolf JL, Linker CA.

Prog Clin Biol Res. 1994;389:505-11. No abstract available.

PMID:
7535460
33.

Busulfan plus etoposide as a preparative regimen for autologous bone marrow transplantation for acute myelogenous leukemia: an update.

Linker CA, Damon LE, Ries CA, Rugo HS, Wolf JL.

Semin Oncol. 1993 Aug;20(4 Suppl 4):40-8; quiz 49.

PMID:
8342075
34.
35.
36.

Treatment of acute leukemia in adults.

Linker CA.

Curr Opin Oncol. 1992 Feb;4(1):53-65. Review.

PMID:
1591294
37.

Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report.

Linker CA, Levitt LJ, O'Donnell M, Forman SJ, Ries CA.

Blood. 1991 Dec 1;78(11):2814-22.

39.

The association between high-dose cytarabine neurotoxicity and renal insufficiency.

Damon LE, Mass R, Linker CA.

J Clin Oncol. 1989 Oct;7(10):1563-8.

PMID:
2778484
40.

Pentoxifylline and aplastic anemia.

Mass RD, Venook AP, Linker CA, Zipkin RE.

Ann Intern Med. 1987 Sep;107(3):427-8. No abstract available.

PMID:
3619234
41.

Teniposide (VM-26) and ara-C in the treatment of adult acute lymphoblastic leukemia.

Linker CA, Levitt LJ, O'Donnell M, Ries CA, Forman SJ.

Semin Oncol. 1987 Jun;14(2 Suppl 1):78-85. No abstract available.

PMID:
3473686
42.

Improved results of treatment of adult acute lymphoblastic leukemia.

Linker CA, Levitt LJ, O'Donnell M, Ries CA, Link MP, Forman SJ, Farbstein MJ.

Blood. 1987 Apr;69(4):1242-8.

43.

Management of treatment failures in thrombotic thrombocytopenic purpura.

Liu ET, Linker CA, Shuman MA.

Am J Hematol. 1986 Dec;23(4):347-61.

PMID:
2431618
44.

Hematologic malignancy in sickle cell disease: report of four cases and review of the literature.

Stricker RB, Linker CA, Crowley TJ, Embury SH.

Am J Hematol. 1986 Feb;21(2):223-30.

PMID:
3455791
45.

The role of splenectomy in multimodality treatment of thrombotic thrombocytopenic purpura.

Schneider PA, Rayner AA, Linker CA, Schuman MA, Liu ET, Hohn DC.

Ann Surg. 1985 Sep;202(3):318-22.

46.

Prednisone therapy of post-transfusion purpura.

Weisberg LJ, Linker CA.

Ann Intern Med. 1984 Jan;100(1):76-7. No abstract available.

PMID:
6537880
47.

Computerized tomography in the diagnosis of systemic candidiasis in patients with acute leukemia.

Linker CA, DeGregorio MW, Ries CA.

Med Pediatr Oncol. 1984;12(6):380-5.

PMID:
6503858
48.

Kinetics and sensitivity of daunorubicin in patients with acute leukemia.

DeGregorio MW, Holleran WM, Macher BA, Linker CA, Wilbur JR.

Cancer Chemother Pharmacol. 1984;13(3):230-4.

PMID:
6488444
49.
50.

Fungal infections in patients with acute leukemia.

DeGregorio MW, Lee WM, Linker CA, Jacobs RA, Ries CA.

Am J Med. 1982 Oct;73(4):543-8.

PMID:
7124778

Supplemental Content

Loading ...
Support Center